Clinical Features	Time to Death		AGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE		PATHOLOGY.T		PATHOLOGY.N		PATHOLOGICSPREAD(M)		TUMOR.STAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
CDC27	4 (4%)	94	0.60311	1	0.7775	1	0.58889	1	NA	NA	0.78027	1	NA	NA	0.12821	1	0.35419	1
MET	7 (7%)	91	0.68969	1	0.88664	1	1	1	NA	NA	1	1	NA	NA	0.80634	1	0.89385	1
IL32	4 (4%)	94	1.5765e-14	7.09e-13	0.36193	1	0.30427	1	NA	NA	0.78027	1	NA	NA	0.22263	1	0.67596	1
PCF11	7 (7%)	91	0.82789	1	0.40329	1	0.42635	1	NA	NA	0.86394	1	0.20397	1	0.58448	1	1	1
SFRS2IP	5 (5%)	93	0.23281	1	0.11981	1	0.65012	1	NA	NA	0.10535	1	1	1	0.084687	1	0.32401	1
NF2	6 (6%)	92	0.60311	1	0.13689	1	1	1	NA	NA	0.25166	1	0.05424	1	0.025106	1	0.054628	1
LGI4	4 (4%)	94	0.18938	1	0.9053	1	0.30427	1	NA	NA	0.78027	1	NA	NA	0.70257	1	0.67596	1